Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones
Abstract Background CRISPR/Cas9 editing systems are currently used to generate mutations in a particular gene to mimic a genetic disorder in vitro. Such “disease in a dish” models based on human pluripotent stem cells (hPSCs) offer the opportunity to have access to virtually all cell types of the hu...
Main Authors: | Elie Frank, Michel Cailleret, Constantin Nelep, Pascal Fragner, Jérome Polentes, Elise Herardot, Lina El Kassar, Karine Giraud-Triboult, Christelle Monville, Karim Ben M’Barek |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-023-03327-2 |
Similar Items
-
Pathological modeling of glycogen storage disease type III with CRISPR/Cas9 edited human pluripotent stem cells
by: Lucille Rossiaud, et al.
Published: (2023-05-01) -
The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles
by: Margot Jarrige, et al.
Published: (2021-01-01) -
Efficient CRISPR/Cas9-Mediated Versatile, Predictable, and Donor-Free Gene Knockout in Human Pluripotent Stem Cells
by: Zhongliang Liu, et al.
Published: (2016-09-01) -
Improvement of the knock-in effciency in the genome of human induced pluripotent stem cells using the CRISPR/Cas9 system
by: М. М. Gridina
Published: (2019-01-01) -
An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells
by: Jianying Guo, et al.
Published: (2017-01-01)